Definitely no capacity at the moment to pay dividends from earnings. Won't be for a few years I would guess with the currently announced expansion plans.
My Current take is:
MEL:
M1 : By far their standout facility & I would say the number 1 market. I think it will fair well from having the Demand but less of the supply that we may see in Sydney.
M2: It's something you have to do, but at the start it will bastardise your return from Melbourne. I do like that it is actually geographically spread, unlike how Equinix/GS tend to expand in Sydney (though they get amazing scaling benefits from doing so). Big facility means its going to take a long time to fill.
SYD:
S1: Obviously the other good market to be in, definitely much more supply has come online with a lot of large facilities. Big expansions in terms of Global Switch Syd East, Equinix SY4, Digital Realty, Fujitsu, HP, etc will mean more competition. Prob 7-8th Largest in this market now.
QLD:
B1 : Looks pretty good & shows you the value that can be created in a full/nearly full facility. But she's only a baby.
B2 : Jury is out for me on how they will do filling the facility. Definitely don't get the scale benefits of SYD & MEL, $/MW ends up being much higher.
WA: Flop.
ACT: Undecided (Likely very slow burn, but prospects are better than WA).
I think it would be prudent to look at getting ready to do a capital raise in the next 6 months at these prices imo.
They have a $100M facility, & ~$190M in Cash/Term Deposits. So $290M working Capital.
FY17 they are forecast to Spend $200-$240M depending on timing. Which means some of B2/M2 cost will fall in FY18. In any event they will need more capital to get them through FY18, unless they restrict expansion.
- Forums
- ASX - By Stock
- We're in to the 200 !!!
NXT
nextdc limited
Add to My Watchlist
1.05%
!
$14.19

Definitely no capacity at the moment to pay dividends from...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$14.19 |
Change
-0.150(1.05%) |
Mkt cap ! $9.087B |
Open | High | Low | Value | Volume |
$14.51 | $14.63 | $14.17 | $35.40M | 2.482M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 32553 | $14.19 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.28 | 100 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 420 | 14.160 |
5 | 2064 | 14.100 |
1 | 2000 | 14.030 |
1 | 2000 | 14.020 |
2 | 284 | 14.010 |
Price($) | Vol. | No. |
---|---|---|
14.450 | 200 | 1 |
14.590 | 1000 | 1 |
14.600 | 500 | 1 |
14.640 | 500 | 1 |
14.690 | 687 | 1 |
Last trade - 16.15pm 27/06/2025 (20 minute delay) ? |
Featured News
NXT (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online